Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases

Gastroenterology

Volumn 149, Issue 5, 2015, Pages 1265-1274.e3

  Dubinsky, Marla ^a   Braun, Jonathan ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gastrointestinal Disease; Genetics; Genomics; Immunology

Indexed keywords

BIOLOGICAL MARKER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; STAT3 PROTEIN; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADAPTIVE IMMUNITY; ARTICLE; BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; ENTERIC FEEDING; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EUBACTERIUM RECTALE; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; KLEBSIELLA PNEUMONIAE; MICROBIOME; MICROFLORA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SACCHAROMYCES CEREVISIAE; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; BLOOD; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL TRACT; IMMUNOLOGY; MICROBIOLOGY;

BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; MICROBIOTA; PROGNOSIS;

EID: 84943246777     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.08.006     Document Type: Article

References (119)

1. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu Rev Immunol 28 2010 573 621
2. R.K. Sellon, S. Tonkonogy, M. Schultz, and et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice Infect Immun 66 1998 5224 5231
3. W.S. Garrett, G.M. Lord, S. Punit, and et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system Cell 131 2007 33 45
4. E. Elinav, T. Strowig, A.L. Kau, and et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis Cell 145 2011 745 757
5. J. Jacobs, and J. Braun Host genes and their effect on the intestinal microbiome garden Genome Med 6 2014 119
6. D. Knights, M.S. Silverberg, R.K. Weersma, and et al. Complex host genetics influence the microbiome in inflammatory bowel disease Genome Med 6 2014 107
7. G.R. D'Haens, K. Geboes, M. Peeters, and et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 1998 262 267
8. A.D. Kostic, R.J. Xavier, and D. Gevers The microbiome in inflammatory bowel disease: current status and the future ahead Gastroenterology 146 2014 1489 1499
9. D.N. Frank, A.L. St Amand, R.A. Feldman, and et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc Natl Acad Sci U S A 104 2007 13780 13785
10. B.P. Willing, J. Dicksved, J. Halfvarson, and et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes Gastroenterology 139 2010 1844 1854 e1
11. X.C. Morgan, T.L. Tickle, H. Sokol, and et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment Genome Biol 13 2012 R79
12. D. Gevers, S. Kugathasan, L.A. Denson, and et al. The treatment-naive microbiome in new-onset Crohn's disease Cell Host Microbe 15 2014 382 392
13. D. Lee, L. Albenberg, C. Compher, and et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases Gastroenterology 148 2015 1087 1106
14. I.D. Iliev, V.A. Funari, K.D. Taylor, and et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis Science 336 2012 1314 1317
15. J.M. Norman, S.A. Handley, M.T. Baldridge, and et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease Cell 160 2015 447 460
16. S. Minot, R. Sinha, J. Chen, and et al. The human gut virome: inter-individual variation and dynamic response to diet Genome Res 21 2011 1616 1625
17. J.P. Jacobs, and J. Braun Immune and genetic gardening of the intestinal microbiome FEBS Lett 588 2014 4102 4111
18. C. Huttenhower, A.D. Kostic, and R.J. Xavier Inflammatory Bowel Disease as a Model for Translating the Microbiome Immunity 40 2014 843 854
19. J. Li, J. Butcher, D. Mack, and et al. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease Inflamm Bowel Dis 21 2015 139 153
20. D. Berry, and W. Reinisch Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? Best Pract Res Clin Gastroenterol 27 2013 47 58
21. M. Tong, X. Li, L. Wegener Parfrey, and et al. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease PLoS One 8 2013 e80702
22. X.C. Morgan, B. Kabakchiev, L. Waldron, and et al. Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease Genome Biol 16 2015 67
23. L.K. Ursell, H.J. Haiser, W. Van Treuren, and et al. The intestinal metabolome: an intersection between microbiota and host Gastroenterology 146 2014 1470 1476
24. H. Duboc, S. Rajca, D. Rainteau, and et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases Gut 62 2013 531 539
25. S. Devkota, Y. Wang, M.W. Musch, and et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice Nature 487 2012 104 108
26. A. Barcenilla, S.E. Pryde, J.C. Martin, and et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl.Environ Microbiol 66 2000 1654 1661
27. G.T. Macfarlane, and S. Macfarlane Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria Scand.J Gastroenterol. Suppl 222 1997 3 9
28. G. D'Argenio, and G. Mazzacca Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer Adv Exp Med Biol 472 1999 149 158
29. G.D. Wu, C. Compher, E.Z. Chen, and et al. Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production Gut 2014 pii: gutjnl-2014-308209. doi: 10.1136/gutjnl-2014-3082 (in press).
30. N. Arpaia, C. Campbell, X. Fan, and et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation Nature 504 2013 451 455
31. Y. Furusawa, Y. Obata, S. Fukuda, and et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells Nature 504 2013 446 450
32. P.M. Smith, M.R. Howitt, N. Panikov, and et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis Science 341 2013 569 573
33. D. Kotlarz, R. Beier, D. Murugan, and et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy Gastroenterology 143 2012 347 355
34. M.A. Farmer, J.P. Sundberg, I.J. Bristol, and et al. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice Proc Natl Acad Sci U S A 98 2001 13820 13825
35. K.L. Kolho, K. Korpela, T. Jaakkola, and et al. Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation Am J Gastroenterol 110 2015 921 930
36. H. Sokol, and P. Langella Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitzii Inflamm Bowel Dis 20 2014 E18
37. K. Gerasimidis, M. Bertz, L. Hanske, and et al. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition Inflamm Bowel Dis 20 2014 861 871
38. H. Sokol, B. Pigneur, L. Watterlot, and et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients Proc Natl Acad Sci U S A 105 2008 16731 16736
39. S. Michail, M. Durbin, D. Turner, and et al. Alterations in the gut microbiome of children with severe ulcerative colitis Inflamm Bowel Dis 18 2012 1799 1808
40. N.G. Rossen, S. Fuentes, M.J. van der Spek, and et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis Gastroenterology 149 2015 110 118
41. M. Tong, J.P. Jacobs, I.H. McHardy, and et al. Sampling of Intestinal Microbiota and Targeted Amplification of Bacterial 16S rRNA Genes for Microbial Ecologic Analysis Curr Protoc Immunol 107 2014 7 41 1-7 41 11
42. V. De Preter, and K. Verbeke Metabolomics as a diagnostic tool in gastroenterology World J Gastrointest Pharmacol Ther 4 2013 97 107
43. M. Storr, H.J. Vogel, and R. Schicho Metabolomics: is it useful for inflammatory bowel diseases? Curr Opin Gastroenterol 29 2013 378 383
44. E.P. Nyangale, D.S. Mottram, and G.R. Gibson Gut microbial activity, implications for health and disease: the potential role of metabolite analysis J Proteome Res 11 2012 5573 5585
45. J. Jansson, B. Willing, M. Lucio, and et al. Metabolomics reveals metabolic biomarkers of Crohn's disease PLoS One 4 2009 e6386
46. H.R. Williams, I.J. Cox, D.G. Walker, and et al. Characterization of inflammatory bowel disease with urinary metabolic profiling Am J Gastroenterol 104 2009 1435 1444
47. A. Kaever, M. Landesfeind, K. Feussner, and et al. MarVis-Pathway: integrative and exploratory pathway analysis of non-targeted metabolomics data Metabolomics 11 2015 764 777
48. J.J. Goedert, J.N. Sampson, S.C. Moore, and et al. Fecal metabolomics: assay performance and association with colorectal cancer Carcinogenesis 2014
49. M.S. Donia, P. Cimermancic, C.J. Schulze, and et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics Cell 158 2014 1402 1414
50. A. Heinken, M.T. Khan, G. Paglia, and et al. Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe J Bacteriol 196 2014 3289 3302
51. P. Cimermancic, M.H. Medema, J. Claesen, and et al. Insights into Secondary Metabolism from a Global Analysis of Prokaryotic Biosynthetic Gene Clusters Cell 158 2014 412 421
52. N.W. Palm, M.R. de Zoete, T.W. Cullen, and et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease Cell 158 2014 1000 1010
53. J.M. Shapiro, J.H. Cho, B.E. Sands, and et al. Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot? Clin Gastroenterol Hepatol 13 2015 842 846
54. A.L. Kau, J.D. Planer, J. Liu, and et al. Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy Sci Transl Med 7 2015 276ra24
55. H.S. Said, W. Suda, S. Nakagome, and et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers DNA Res 21 2014 15 25
56. M.J. Docktor, B.J. Paster, S. Abramowicz, and et al. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease Inflamm Bowel Dis 18 2012 935 942
57. J.G. Caporaso, C.L. Lauber, E.K. Costello, and et al. Moving pictures of the human microbiome Genome Biol 12 2011 R50
58. B. Sendid, J.F. Colombel, P.M. Jacquinot, and et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease Clin Diagn Lab Immunol 3 1996 219 226
59. J.F. Quinton, B. Sendid, D. Reumaux, and et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role Gut 42 1998 788 791
60. B. Sendid, J.F. Quinton, G. Charrier, and et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease Am J Gastroenterol 93 1998 1306 1310
61. T.B. Murdoch, W. Xu, J.M. Stempak, and et al. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease Inflamm Bowel Dis 18 2012 1743 1748
62. F. Vasseur, B. Sendid, T. Jouault, and et al. Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels Inflamm Bowel Dis 18 2012 430 438
63. F. Vasseur, B. Sendid, F. Broly, and et al. The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn's disease BMC Med Genet 14 2013 35
64. D. Basso, C.F. Zambon, and M. Plebani Inflammatory bowel diseases: from pathogenesis to laboratory testing Clin Chem Lab Med 52 2014 471 481
65. O. Cohavy, G. Harth, M. Horwitz, and et al. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease Infect Immun 67 1999 6510 6517
66. F. Rieder, R. Lopez, A. Franke, and et al. Characterization of changes in serum anti-glycan antibodies in Crohn's disease-a longitudinal analysis PLoS One 6 2011 e18172
67. P. Ricanek, G. Perminow, M. Cvancarova-Smastuen, and et al. Reproducibility of serologic antibody activity at diagnosis and after treatment in ulcerative colitis (UC) and Crohn's disease (CD). A prospective population based study Gut 61 suppl 3 2012 A277
68. A. Eser, P. Papay, C. Primas, and et al. The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease Aliment Pharmacol Ther 35 2012 292 299
69. L. Viitasalo, L. Niemi, M. Ashorn, and et al. Early microbial markers of celiac disease J Clin Gastroenterol 48 2014 620 624
70. A. Mankai, W. Sakly, Y. Thabet, and et al. Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus Rheumatol Int 33 2013 665 669
71. D. Wallis, A. Asaduzzaman, M. Weisman, and et al. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study Arthritis Res Ther 15 2013 R166
72. M. Banati, P. Csecsei, E. Koszegi, and et al. Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system Eur J Neurol 20 2013 1492 1495
73. D.B. Shor, H. Orbach, M. Boaz, and et al. Gastrointestinal-associated autoantibodies in different autoimmune diseases Am J Clin Exp Immunol 1 2012 49 55
74. M. Peeters, S. Joossens, S. Vermeire, and et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease Am J Gastroenterol 96 2001 730 734
75. E.J. Hoffenberg, S. Fidanza, and A. Sauaia Serologic testing for inflammatory bowel disease J Pediatr 134 1999 447 452
76. M.C. Dubinsky, J.J. Ofman, M. Urman, and et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease Am J Gastroenterol 96 2001 758 765
77. M.C. Dubinsky, J.F. Johanson, E.G. Seidman, and et al. Suspected inflammatory bowel disease-the clinical and economic impact of competing diagnostic strategies Am J Gastroenterol 97 2002 2333 2342
78. A. Zholudev, D. Zurakowski, W. Young, and et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype Am J Gastroenterol 99 2004 2235 2241
79. M. Joossens, K. Van Steen, J. Branche, and et al. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease Inflamm Bowel Dis 16 2010 58 67
80. P. Pavlidis, O. Romanidou, D. Roggenbuck, and et al. Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease Clin Dev Immunol 2012 2012 640835
81. E.A. Vasiliauskas, S.E. Plevy, C.J. Landers, and et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup Gastroenterology 110 1996 1810 1819
82. P. Pavlidis, Z. Shums, A.L. Koutsoumpas, and et al. Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA Clin Chim Acta 441 2015 176 181
83. L. Frehn, A. Jansen, E. Bennek, and et al. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases PLoS One 9 2014 e106750
84. C.S. Yu, J.H. Pemberton, and D. Larson Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results Dis Colon Rectum 43 2000 1487 1496
85. R. Panaccione, and W.J. Sandborn Is antibody testing for inflammatory bowel disease clinically useful? Gastroenterology 116 1999 1001 1002 discussion 1002-1003
86. F.M. Ruemmele, S.R. Targan, G. Levy, and et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease Gastroenterology 115 1998 822 829
87. G.E. Reese, V.A. Constantinides, C. Simillis, and et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease Am J Gastroenterol 101 2006 2410 2422
88. S. Joossens, W. Reinisch, S. Vermeire, and et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study Gastroenterology 122 2002 1242 1247
89. S. Joossens, J.F. Colombel, C. Landers, and et al. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis Gut 55 2006 1667 1669
90. S.R. Targan, C.J. Landers, H. Yang, and et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease Gastroenterology 128 2005 2020 2028
91. S.P. Sura, A. Ahmed, A.S. Cheifetz, and et al. Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis J Clin Gastroenterol 48 2014 351 355
92. G.B. Chen, S.H. Lee, M.J. Brion, and et al. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data Hum Mol Genet 23 2014 4710 4720
93. S. Singh, P.K. Sharma, E.V. Loftus Jr., and et al. Meta-analysis: serological markers and the risk of acute and chronic pouchitis Aliment Pharmacol Ther 37 2013 867 875
94. P. Fleshner, A. Ippoliti, M. Dubinsky, and et al. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis Clin Gastroenterol Hepatol 6 2008 56156 56158
95. Q. Le, G. Melmed, M. Dubinsky, and et al. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease Inflamm Bowel Dis 19 2013 30 36
96. G.Y. Melmed, P.R. Fleshner, O. Bardakcioglu, and et al. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis Dis Colon Rectum 51 2008 100 108
97. L.Y. Tang, H. Cai, U. Navaneethan, and et al. Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch Int J Colorectal Dis 27 2012 1455 1463
98. J.A. Coukos, L.A. Howard, J.M. Weinberg, and et al. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis Dig Dis Sci 57 2012 1544 1553
99. A.D. Tyler, R. Milgrom, W. Xu, and et al. Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis Clin Gastroenterol Hepatol 10 2012 507 512
100. E.A. Vasiliauskas, L.Y. Kam, L.C. Karp, and et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics Gut 47 2000 487 496
101. M. Ferrante, L. Henckaerts, M. Joossens, and et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour Gut 56 2007 1394 1403
102. M.C. Dubinsky, S. Kugathasan, L. Mei, and et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children Clin Gastroenterol Hepatol 6 2008 1105 1111
103. Y. Xiong, G.Z. Wang, J.Q. Zhou, and et al. Serum antibodies to microbial antigens for Crohn's disease progression: a meta-analysis Eur J Gastroenterol Hepatol 26 2014 733 742
104. J.D. Ryan, M.S. Silverberg, W. Xu, and et al. Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort Aliment Pharmacol Ther 38 2013 274 283
105. G.R. Lichtenstein, S.R. Targan, M.C. Dubinsky, and et al. Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior Inflamm Bowel Dis 17 2011 2488 2496
106. C.A. Siegel, L.S. Siegel, J.S. Hyams, and et al. Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease Inflamm Bowel Dis 17 2011 30 38
107. C.A. Siegel, H. Horton, L.S. Siegel, and et al. A Validated Web-Based Patient Communication Tool to Display Individualized Crohn's Disease Predicted Outcomes Based on Clinical, Serologic and Genetic Variables Gastroenterology 146 2014 S-433 S-434
108. X. Han, K. Uchida, I. Jurickova, and et al. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease Gastroenterology 136 2009 1261 1271 e1-3
109. J.R. Korzenik, B.K. Dieckgraefe, J.F. Valentine, and et al. Sargramostim for active Crohn's disease N Engl J Med 352 2005 2193 2201
110. M.A. McGuckin, R. Eri, L.A. Simms, and et al. Intestinal barrier dysfunction in inflammatory bowel diseases Inflamm Bowel Dis 15 2009 100 113
111. D. Hollander, C.M. Vadheim, E. Brettholz, and et al. Increased intestinal permeability in Crohn's patients and their relatives: an etiologic factor? Ann Int Med 105 1986 883 885
112. K.D. Katz, D. Hollander, C.M. Vadheim, and et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives Gastroenterology 97 1989 927 931
113. K. Teahon, P. Smethurst, A.J. Levi, and et al. Intestinal permeability in patients with Crohn's disease and their first degree relatives Gut 33 1992 320 323
114. R. D'Inca, V. Annese, V. di Leo, and et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease Aliment Pharmacol Ther 23 2006 1455 1461
115. J. Halfvarson, A. Standaert-Vitse, G. Jarnerot, and et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease Gut 54 2005 1237 1243
116. S.M. Devlin, H. Yang, A. Ippoliti, and et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives Gastroenterology 132 2007 576 586
117. L. Mei, S.R. Targan, C.J. Landers, and et al. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease Gastroenterology 130 2006 1078 1085
118. F.D. van Schaik, B. Oldenburg, A.R. Hart, and et al. Serological markers predict inflammatory bowel disease years before the diagnosis Gut 62 2013 683 688
119. E. Israeli, I. Grotto, B. Gilburd, and et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease Gut 54 2005 1232 1236